Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge. - Wikidata - awgldk - TriplyDB

Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge.

Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge.

http://www.wikidata.org/entity/Q33768989

about

Innate Immunity and Immune Evasion by Enterovirus 71 Toll-like receptor pre-stimulation protects mice against lethal infection with highly pathogenic influenza viruses.Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi.Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model.Toll-like receptor 4 is essential to preserving cardiac function and survival in low-grade polymicrobial sepsis.Administration of a synthetic TLR4 agonist protects mice from pneumonic tularemia.Carbohydrate-based immune adjuvants.The TLR4-TRIF pathway protects against H5N1 influenza virus infection Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues Inducible innate resistance of lung epithelium to infection.Gene expression profiles identify both MyD88-independent and MyD88-dependent pathways involved in the maturation of dendritic cells mediated by heparan sulfate: a novel adjuvant.Toll-like receptors and leishmaniasis.Toll-like receptor modulation in cardiovascular disease: a target for intervention?Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation Synergistic interactions of TLR2/6 and TLR9 induce a high level of resistance to lung infection in mice.Transient lipopolysaccharide-induced resistance to aerosolized Bacillus anthracis in New Zealand white rabbits.Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant.Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer.Intranasal vaccination promotes detrimental Th17-mediated immunity against influenza infection.Lipopolysaccharide, CD14 and Toll-like receptors: an emerging link between innate immunity and atherosclerotic disease.Prophylactic and therapeutic implications of toll-like receptor ligands.Moraxella catarrhalis: from interactions with the host immune system to vaccine development.Adjuvant immunotherapies as a novel approach to bacterial infections.TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease.CD14 is critical for TLR2-mediated M1 macrophage activation triggered by N-glycan recognition.The stimulatory effect of the TLR4-mediated adjuvant glucopyranosyl lipid A is well preserved in old age.TLR4 agonists as immunomodulatory agents.Immunostimulation with macrophage-activating lipopeptide-2 increased survival in murine pneumonia.Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitro.Strategies to Stimulate Innate Immunity for Designing Effective Vaccine Adjuvants

P2860

Q26773329-7AF24A18-B3EF-4B35-9D1F-6383A643B619 Q30400432-8A50DBF4-FF44-4CBE-8895-F5099AC14485 Q33601917-C958B455-9D2E-4957-B6E2-CEE60FF6DD95 Q33676552-58BF57D2-815A-4B22-A41F-CF158707D9CD Q34543367-ED595B77-DA57-4CAA-BBB4-4A41F43779EB Q34714290-C081C426-38A9-4507-ACD9-128A234EFADF Q35054845-7425E84D-3FCA-4C5F-93EB-4CE992A77AF8 Q35665940-3DF37BCA-F793-49CF-81C7-9B3889F8A9DD Q35737359-1D6A2EAA-CD3D-4DBB-87F0-511917E6E483 Q35754472-668BD676-8274-41B6-830B-1E8F6609B9EA Q35886513-8BD5DFEF-A675-405D-9962-CEE8D973E3EC Q36483521-260587E7-FD54-48CD-960A-837CA5E0EBC7 Q36543054-F31EAE67-5234-4839-B836-BDB9E3A98F77 Q36718650-3E511CF9-EAA3-42D0-ADBB-9DF5101B4EB4 Q36732312-1F78CDA7-89BB-4E69-85B2-CAEC4F494C91 Q36845161-CE463B42-80BC-446C-8398-0AE1D78A1E1B Q36949041-78DCB0B5-4EBF-4957-96CB-F91DE63CFD74 Q36960814-AB7AA8D2-E55F-4D32-9F3D-56ADC38925C8 Q36968286-65C55231-9E68-45BC-B8CE-65AC28DAB770 Q37497786-FE774D42-5B87-4E77-9594-41F031B837AE Q37510582-D091C901-7D70-4152-A08E-6CC0FD26B2B3 Q37608487-57CE9346-F929-4EF2-9A1D-7D9E746DBC54 Q37989884-D02692A7-4D87-4BA0-8EEF-CC5E12B6FFB4 Q38041190-EDDB05DB-D702-4F2B-9D4E-F6BF7E722631 Q38096056-5E282627-88EC-4CDD-859A-802EBE097AA7 Q38195597-967CD5AF-D85F-450F-BAFD-875FDB03A875 Q40110484-5B719D21-F137-4ADC-BCE7-626B0B31C2C2 Q41246444-A57345B7-6C71-4470-A008-53B7E71DFA22 Q50076068-8B76DE7D-2A8A-47BD-87DA-565421DA09CE Q52915313-94E22F4A-8D04-42C5-8BB4-C021F00431F5 Q53749471-1EC9DFB2-759E-4C21-9031-6ACCB21409AA Q57198394-308A1387-397F-4BE7-9BF2-CBE28283EB44

P2860

Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge.

http://www.wikidata.org/entity/Q33768989

description

2005 nî lūn-bûn

@nan

2005 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Synthetic toll-like receptor 4 ...... tance to infectious challenge.

@ast

Synthetic toll-like receptor 4 ...... tance to infectious challenge.

@en

type

label

Synthetic toll-like receptor 4 ...... tance to infectious challenge.

@ast

Synthetic toll-like receptor 4 ...... tance to infectious challenge.

@en

prefLabel

Synthetic toll-like receptor 4 ...... tance to infectious challenge.

@ast

Synthetic toll-like receptor 4 ...... tance to infectious challenge.

@en

P1433

Q33768989-77F34F19-2070-4A31-A843-4F565887DA62

P1476

Q33768989-4E8A87DB-6969-420B-B9BE-67D1259C27BE

P2093

Q33768989-00BB8022-86D1-47B6-BFE9-DA56FB57B79A

Q33768989-1449F548-C740-44B2-AF9D-F98003797635

Q33768989-64D0D816-80ED-49B0-B352-C6AC8C492EC6

Q33768989-705E1A32-8F08-4579-BA95-B7D0320C1F19

Q33768989-7FE44F70-6E4E-4A66-A723-F9306702D76B

Q33768989-8638C126-4B7A-435F-B1D5-4970B9CBB5C5

Q33768989-900835B9-D051-4F74-B037-9276854A0070

Q33768989-964E2CA1-566B-4157-9790-02DEB7E9BA53

Q33768989-B9156DA5-B514-41DA-A0B7-1057E963811D

Q33768989-C4E136DE-0755-4EBB-B565-DFB1B0019F18

P2860

Q33768989-059E06B6-C25E-46FE-9591-5805B414CF9F

Q33768989-0781915B-F255-4F9B-8BE8-056A56DBA4F1

Q33768989-11CFF106-99BA-4051-8A84-4910536E9743

Q33768989-16D91A06-8BA1-4650-A2ED-EC72C7462ED5

Q33768989-1E67D22F-1F28-4DBA-904F-EFE85C3A3577

Q33768989-2A0CCCF5-3364-4556-9340-4E490B7CDA17

Q33768989-2ADB7AD0-E4B9-4BC5-9A65-400A5B7B5399

Q33768989-300525BD-2EA0-4618-839B-A5F147E7EED4

Q33768989-39C1563F-2273-4206-AE90-00A8E1484CD1

Q33768989-40A4BDE9-69C5-44A1-ABDE-B54A6CE8F4C0

P304

Q33768989-125A29E0-7977-4243-8BC1-979A2CB7B87A

P31

Q33768989-24C444F1-45B7-4B18-8681-D77D89A0E25D

P356

Q33768989-9D820B13-4C1D-481A-88C0-E302DB2E127C

P407

Q33768989-F6578440-4D44-4210-A6AD-7F1DBE1141FE

P433

Q33768989-80D92812-277E-4A4A-A7F1-F72268E03F17

P478

Q33768989-C44B30EE-FDBB-4671-8B5E-D40E801C38BA

P50

Q33768989-B763C7AF-42B1-4F50-83A6-D7942C8D848F

P577

Q33768989-8B08347E-3ACC-45D8-87FC-F7CEB8465B60

P698

Q33768989-50A1EB8C-5E65-4F47-8BEE-F1018669CC1E

P921

Q33768989-d9750f4a-fe86-4103-b419-2299c0311c93

P932

Q33768989-F27D26D8-3C03-49DB-8A00-A3EFC11DD0FD

P356

IAI.73.5.3044-3052.2005

P1433

Infection and Immunity

P1476

Synthetic toll-like receptor 4 ...... stance to infectious challenge

@en

P2093

Axel G Stöver

http://www.w3.org/2001/XMLSchema#string

Christopher W Cluff

http://www.w3.org/2001/XMLSchema#string

Craig L Johnson

http://www.w3.org/2001/XMLSchema#string

David A Johnson

http://www.w3.org/2001/XMLSchema#string

David H Persing

http://www.w3.org/2001/XMLSchema#string

Jory R Baldridge

http://www.w3.org/2001/XMLSchema#string

Mark T Livesay

http://www.w3.org/2001/XMLSchema#string

Michael J Lacy

http://www.w3.org/2001/XMLSchema#string

Robert M Hershberg

http://www.w3.org/2001/XMLSchema#string

Valerie G Clawson

http://www.w3.org/2001/XMLSchema#string

P2860

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

Genetic and Physical Mapping of theLpsLocus: Identification of the Toll-4 Receptor as a Candidate Gene in the Critical Region

Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease

Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4

The role of disulfide bonds in the assembly and function of MD-2

Crystal structure of human GM2-activator protein with a novel beta-cup topology

Structural analysis of lipid complexes of GM2-activator protein

Innate immune recognition: mechanisms and pathways

Separate functional domains of human MD-2 mediate Toll-like receptor 4-binding and lipopolysaccharide responsiveness

Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria

P304

3044-3052

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.73.5.3044-3052.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15845512

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

1087352

http://www.w3.org/2001/XMLSchema#string